Price Controls on Drugs Are Absurd

The average cancer specialist brought home nearly $300,000 last year. One in 10 earned more than $500,000. Considering cancer’s stubbornly high death rate, say 118 of the nation’s most prominent drug producers, such high compensation doesn’t make sense.

They have jointly called on Congress to step in with salary caps for oncologists.

Sound far-fetched? That’s because it is.

Read Full Article »
Comment
Show commentsHide Comments

Related Articles